- For Patients
- Introduction to the Marshall Protocol
- Length of the MP
- Immunopathology
- Managing immunopathology
- Food and drink
- Light restriction
- Vitamin D metabolite calculator - get feedback on vitamin D results
- Therapeutic probe - best method for determining MP suitability
- Starting the Marshall Protocol
- Resources for patients
- Marshall Protocol summary
- Palliative vs. curative treatments
- Patient interviews on Bacteriality
- Non-MP treatments
- Glossary
- The Protocol
- Marshall Protocol summary
- Publications and presentations
- Science behind immunopathology
- Science behind olmesartan (Benicar)
- Safety of olmesartan
- Resources for physicians
- Vitamin D metabolite calculator - get feedback on vitamin D results
- Therapeutic probe - best method for determining MP suitability
- Physicians' concerns about the MP
- Notice for emergency medical personnel
- The Pathogenesis
- Publications and presentations
- Science behind Marshall Pathogenesis
- Microbes in the human body
- Successive infection and variability in disease
- Autoimmune theory of disease
- Science behind vitamin D
- Metabolism of vitamin D and the VDR
- Th1 Spectrum Disorder - how chronic inflammatory diseases are related
- Transmission of bacteria and onset of chronic disease
- Evolutionary perspective on disease
- Incidence and prevalence of disease
- Evidence that chronic disease is caused by pathogens
- Diseases
- Foundation
- Related Sites
Differences
This shows you the differences between two versions of the page.
| Both sides previous revisionPrevious revision | Last revisionBoth sides next revision | ||
| home:publications:marshall_chlamydia1_2009 [01.03.2012] – external edit 127.0.0.1 | home:publications:marshall_chlamydia1_2009 [04.23.2012] – [Presentation - The Marshall Protocol in a Clinical Environment - Observations from the Initial Cohort] paulalbert | ||
|---|---|---|---|
| Line 4: | Line 4: | ||
| ====== Presentation - The Marshall Protocol in a Clinical Environment - Observations from the Initial Cohort ====== | ====== Presentation - The Marshall Protocol in a Clinical Environment - Observations from the Initial Cohort ====== | ||
| - | {{ vimeo> | + | |
| **Type:** Conference presentation\\ | **Type:** Conference presentation\\ | ||
| Line 11: | Line 11: | ||
| **Location: | **Location: | ||
| **Date: | **Date: | ||
| - | **See also:** [[http:// | + | **See also:** [[http:// |
| ===== Transcript ===== | ===== Transcript ===== | ||
home/publications/marshall_chlamydia1_2009.txt · Last modified: 07.04.2022 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.